Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From... von HEHLMANN, Rüdiger, MÜLLER, Martin C, SCHNITTGER, Susanne, EINSELE, Hermann, DENGLER, Jolanta, FALGE, Christiane, KANZ, Lothar, NEUBAUER, Andreas, KNEBA, Michael, STEGELMANN, Frank, PFREUNDSCHUH, Michael, WALLER, Cornelius F, LAUSEKER, Michael, SPIEKERMANN, Karsten, BAERLOCHER, Gabriela M, EHNINGER, Gerhard, HEIM, Dominik, HEIMPEL, Hermann, NERL, Christoph, KRAUSE, Stefan W, HOSSFELD, Dieter K, KOLB, Hans-Jochem, HASFORD, Joerg, HANFSTEIN, Benjamin, SAUSSELE, Susanne, HOCHHAUS, Andreas, FABARIUS, Alice, SCHREIBER, Annette, PROETEL, Ulrike, PLETSCH, Nadine, PFIRRMANN, Markus, HAFERLACH, Claudia

Volltext

Tolerability-Adapted Imatinib 800 mg/d Versus 400 mg/d Versus 400 mg/d Plus Interferon-α in Newly Diagnosed Chronic Myeloid Leukemia von Rüdiger Hehlmann, Michael Lauseker, Susanne Jung-Munkwitz, Armin Leitner, Martin C. Müller, Nadine Pletsch, Ulrike Proetel, Claudia Haferlach, Brigitte Schlegelberger, Leopold Balleisen, Mathias Hänel, Markus Pfirrmann, Stefan W. Krause, Christoph Nerl, Hans Pralle, Alois Gratwohl, Dieter K. Hossfeld, Joerg Hasford, Andreas Hochhaus, Susanne Saußele

Volltext

Allogeneic hematopoietic stem cell transplantation (allo SCT) for chronic myeloid leukemia in the imatinib era: evaluation of its impact within a subgroup of the randomized German... von Saussele, Susanne, Lauseker, Michael, Gratwohl, Alois, Beelen, Dietrich W., Bunjes, Donald, Schwerdtfeger, Rainer, Kolb, Hans-Jochem, Ho, Anthony D., Falge, Christiane, Holler, Ernst, Schlimok, Günter, Zander, Axel R., Arnold, Renate, Kanz, Lothar, Dengler, Robert, Haferlach, Claudia, Schlegelberger, Brigitte, Pfirrmann, Markus, Müller, Martin C., Schnittger, Susanne, Leitner, Armin, Pletsch, Nadine, Hochhaus, Andreas, Hasford, Joerg, Hehlmann, Rüdiger, for the German CML Study Group

Volltext

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV von Proetel, Ulrike, Pletsch, Nadine, Lauseker, Michael, Müller, Martin C., Hanfstein, Benjamin, Krause, Stefan W., Kalmanti, Lida, Schreiber, Annette, Heim, Dominik, Baerlocher, Gabriela M., Hofmann, Wolf-Karsten, Lange, Elisabeth, Einsele, Hermann, Wernli, Martin, Kremers, Stephan, Schlag, Rudolf, Müller, Lothar, Hänel, Mathias, Link, Hartmut, Hertenstein, Bernd, Pfirrmann, Markus, Hochhaus, Andreas, Hasford, Joerg, Hehlmann, Rüdiger, Saußele, Susanne

Volltext

Elderly CML Patients On Early Applied High Dose Imatinib Achieve Molecular Remissions As Fast As Younger Patients In Contrast To Patients On Standard Dose Imatinib: A Subanalysis O... von Proetel, Ulrike, Pletsch, Nadine, Lauseker, Michael, Kalmanti, Lida, Schreiber, Annette, Müller, Martin C., Hanfstein, Benjamin, Krause, Stefan W., Heim, Dominik, Baerlocher, Gabriela M., Hofmann, Wolf-Karsten, Lange, Elisabeth, Einsele, Hermann, Wernli, Martin, Kremers, Stephan, Schlag, Rudolf, Müller, Lothar, Hänel, Matthias, Link, Hartmut, Hertenstein, Bernd, Pfirrmann, Markus, Hochhaus, Andreas, Hasford, Joerg, Hehlmann, Rüdiger, Saussele, Susanne

Volltext

Evolution of Blast Crisis (BC) in Chronic Myeloid Leukemia (CML) in the Imatinib-Era: A Rare Event with High Proportions of Low Risk Patients and of Early Bc; Need for Rapid Detect... von Saussele, Susanne, Lauseker, Michael, Pfirrmann, Markus, Leitner, Armin, Pletsch, Nadine, Stegelmann, Frank, Ho, Anthony D, Schlimok, Günter, Lindemann, Albrecht, Beelen, Dietrich W, Gratwohl, Alois, Hänel, Mathias, Haferlach, Claudia, Schlegelberger, Brigitte, Müller, Martin C, Erben, Philipp, Schnittger, Susanne, Jung-Munkwitz, Susanne, Shazi, Samina, Hasford, Joerg, Hochhaus, Andreas, Hehlmann, Rüdiger, The German CML Study Group

Volltext

Randomized Comparison of Imatinib 800 Mg Vs. Imatinib 400 Mg +/- IFN in Newly Diagnosed BCR/ABL Positive Chronic Phase CML: Analysis of Molecular Remission at 12 Months; The German... von Hehlmann, Rudiger, Jung-Munkwitz, Susanne, Lauseker, Michael, Leitner, Armin, Pletsch, Nadine, Shazi, Samina, Müller, Martin C., Haferlach, Claudia, Schlegelberger, Brigitte, Schnittger, Susanne, Waller, Cornelius F., Neubauer, Andreas, Kanz, Lothar, Hänel, Mathias, Mayer, Jiri, Stegelmann, Frank, Fuchs, Roland, Berdel, Wolfgang E., Balleisen, Leopold, Pfirrmann, Markus, Ehninger, Gerhard, Fischer, Thomas, Hossfeld, Dieter K., Kolb, Hans- Jochem, Krause, Stefan W., Nerl, Christoph, Pralle, Hans, Gratwohl, Alois, Tobler, Andreas, Heimpel, Hermann, Hasford, Joerg, Hochhaus, Andreas, Saussele, Susanne, The German CML Study Group

Volltext

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) with a Related Donor in Chronic Myeloid Leukemia (CML): An Explanation for Fast Improvement of Survival in Two Consecutive... von Pfirrmann, Markus, Saussele, Susanne, Leitner, Armin, Pletsch, Nadine, Lauseker, Michael, Mueller, Martin C, Haferlach, Claudia, Schlegelberger, Brigitte, Schnittger, Susanne, Ehninger, Gerhard, Fischer, Thomas, Hossfeld, Dieter K, Kolb, Hans-Jochem, Krause, Stefan W, Nerl, Christoph, Pralle, Hans, Tobler, Andreas, Heimpel, Hermann, Beelen, Dietrich W, Zander, Axel R, Bunjes, Donald, Schrezenmeier, Hubert, Feldmann, Ulrike, Mueller, Carlheinz, Baldomero, Helen, Schanz, Urs, Hochhaus, Andreas, Hasford, Joerg, Gratwohl, Alois, Hehlmann, Ruediger, The German CML Study Group

Volltext

Optimaization of Imatinib Therapy by Combination. 5 Year Survival and Response Results of the Pilot Phase of the Randomized German CML STUDY IV von Pletsch, Nadine, Saussele, Susanne, Lauseker, Michael, Leitner, Armin, Jung-Munkwitz, Susanne, Shazi, Samina, Haferlach, Claudia, Schlegelberger, Brigitte, Müller, Martin C, Schenk, Thomas, Schnittger, Susanne, Pfirrmann, Markus, Ehninger, Gerhard, Fischer, Thomas, Hossfeld, Dieter K., Kolb, Hans-Jochem, Krause, Stefan W, Nerl, Christoph, Pralle, Hans, Gratwohl, Alois, Tobler, Andreas, Heimpel, Hermann, Balleisen, Leopold, Einsele, Hermann, Ho, Anthony D., Falge, Christine, Hänel, Mathias, Pfreundschuh, Michael, Kanz, Lothar, Stegelmann, Frank, Köhne, Claus-Henning, Kremers, Stephan, Spiekermann, Karsten, Berdel, Wolfgang E, Waller, Cornelius F., Bentz, Martin, Hasford, Joerg, Hochhaus, Andreas, Hehlmann, Rüdiger, The German CML Study Group

Volltext

Assoziationsanalysen im ˜TGFα- œ[TGF-Alpha-] und ˜TGFβ3-Gen œ[TGF-Beta-3-Gen] bei Patienten mit Lippen-Kiefer-Gaumenspalten und Gaumenspalten

Volltext bestellen

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV von Proetel, Ulrike, Pletsch, Nadine, Lauseker, Michael, Müller, Martin C, Hanfstein, Benjamin, Krause, Stefan W, Kalmanti, Lida, Schreiber, Annette, Heim, Dominik, Baerlocher, Gabriela M, Hofmann, Wolf-Karsten, Lange, Elisabeth, Einsele, Hermann, Wernli, Martin, Kremers, Stephan, Schlag, Rudolf, Müller, Lothar, Hänel, Mathias, Link, Hartmut, Hertenstein, Bernd, Pfirrmann, Markus, Hochhaus, Andreas, Hasford, Joerg, Hehlmann, Rüdiger, Saußele, Susanne

Volltext bestellen

Older patients with chronic myeloid leukemia (≥65 years) profit more from higher imatinib doses than younger patients: a subanalysis of the randomized CML-Study IV von Proetel, Ulrike

Volltext bestellen